Other projects

Topic: Vaccines & Therapeutic clinical trials to boost COVID-19 prevention and treatment

Other projects funded by the HERA Incubator call for expressions of interest on coronavirus variants. The goal of these projects, along with COVend, is to boost COVID-19 prevention and treatment and further inform public health policy and clinical management.

XVR011 Phase 2

ExeVir’s XVR011, a best in class nanobodybased biology that broadly neutralizes SARSCOV-1 and SARS-COV-2


Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOC


Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anticytokine activity